Trial Profile
RCT Comparing Different Ribavirin Dosages and Durations of Treatment in Combination With Peginterferon in HCV Genotypes 2 and 3 (WRITE)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2022
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms WRITE
- 09 Mar 2022 Status changed from recruiting to completed.
- 28 Jun 2011 New trial record